Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (171-180 of 548) with videos related to

Pageof 55
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 23, 2026
Hold the line: Local control strategies in oligoprogressive gynecologic cancers during systemic therapyFilippo Casaccia Giordano, Roberta Lazzari, Gabriella Macchia, et al.
Bulletin Du Cancer|February 25, 2020
[Current advances in immunotherapy in ovarian cancer]Olivia Le Saux, Bertrand Dubois, Marc-Henri Stern, et al.
Gynecologic Oncology|April 18, 2013
A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinomaThomas J Herzog, Giovanni Scambia, Byoung-Gie Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2017
Improving treatment results with reference centres for rare cancers: where do we stand?Isabelle Ray-Coquard, Eric Pujade Lauraine, Axel Le Cesne, et al.
The American Journal of Surgical Pathology|September 10, 2020
Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell TumorsPauline Baillard, Catherine Genestie, Sabrina Croce, et al.
Bulletin Du Cancer|November 24, 2004
[Organization and impact of the multidisciplinary committee in oncology]Patrick Castel, Jean-Yves Blay, Pierre Meeus, et al.
Bulletin Du Cancer|May 18, 2023
[Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group]Andy Karabajakian, Catherine Genestie, Pierre Meeus, et al.
Bulletin Du Cancer|November 21, 2002
[Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network]Thomas Bachelot, Isabelle Ray-Coquard, David Coeffic, et al.
Bulletin Du Cancer|September 13, 2007
[Are antiangiogenic antibodies universal for solid tumor?]Isabelle Ray-Coquard, Thomas Bachelot, Chadi Saba, et al.
Bulletin Du Cancer|March 7, 2006
Medical practices and cancer care networks: examples in oncologyIsabelle Ray-Coquard, Franck Chauvin, Antoine Lurkin, et al.
Pageof 55

Showing results (171-180 of 548) with videos related to

Sort By:
Pageof 55
European Journal of Cancer (Oxford, England : 1990)|June 23, 2026
Hold the line: Local control strategies in oligoprogressive gynecologic cancers during systemic therapyFilippo Casaccia Giordano, Roberta Lazzari, Gabriella Macchia, et al.
Bulletin Du Cancer|February 25, 2020
[Current advances in immunotherapy in ovarian cancer]Olivia Le Saux, Bertrand Dubois, Marc-Henri Stern, et al.
Gynecologic Oncology|April 18, 2013
A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinomaThomas J Herzog, Giovanni Scambia, Byoung-Gie Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2017
Improving treatment results with reference centres for rare cancers: where do we stand?Isabelle Ray-Coquard, Eric Pujade Lauraine, Axel Le Cesne, et al.
The American Journal of Surgical Pathology|September 10, 2020
Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell TumorsPauline Baillard, Catherine Genestie, Sabrina Croce, et al.
Bulletin Du Cancer|November 24, 2004
[Organization and impact of the multidisciplinary committee in oncology]Patrick Castel, Jean-Yves Blay, Pierre Meeus, et al.
Bulletin Du Cancer|May 18, 2023
[Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group]Andy Karabajakian, Catherine Genestie, Pierre Meeus, et al.
Bulletin Du Cancer|November 21, 2002
[Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network]Thomas Bachelot, Isabelle Ray-Coquard, David Coeffic, et al.
Bulletin Du Cancer|September 13, 2007
[Are antiangiogenic antibodies universal for solid tumor?]Isabelle Ray-Coquard, Thomas Bachelot, Chadi Saba, et al.
Bulletin Du Cancer|March 7, 2006
Medical practices and cancer care networks: examples in oncologyIsabelle Ray-Coquard, Franck Chauvin, Antoine Lurkin, et al.
Pageof 55